Navigation

TA155 Macular degeneration (age-related) - ranibizumab and pegaptanib: guidance

The published full technology appraisal on Macular degeneration (age-related) - ranibizumab and pegaptanib including recommendations and methods used.

This page was last updated: 21 May 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.